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ABSTRACT Fluorescence correlation spectroscopy is a potentially powerful tool for measuring protein-protein interactions
directly in single living cells. We previously reported on the detection of homodimer formation in cells using molecular brightness
analysis. Here, we extend the technique to detect binding between different proteins. Proteins are labeled with the ﬂuorescent
markers YFP andCFP.We ﬁrst determine the coexpression ratio of both proteins bymeasuring the intensity ratio with a dual-color
setup. The effect of ﬂuorescence resonance energy transfer on the intensity ratio is explicitly taken into account. The brightness of
cells coexpressing both proteins ismeasured in a single-color setup. Selecting the laser wavelength of the two-photon light source
allows us to either coexcite both proteins or to selectively excite YFP-labeled proteins. This approach enables us to distinguish
between homodimer and heterodimer formation. We ﬁrst present the theory and then demonstrate experimental feasibility using
the ligand binding domains of retinoic acid receptor (RARLBD) and of retinoid X receptor (RXRLBD). Both proteins form
heterodimers, and RXRLBD also forms homodimers in the presence of its agonist. We explore binding between these proteins in
the presence and absence of RXR agonist. Our results demonstrate that brightness analysis offers a quantitative method for
determining protein interactions in cells.
INTRODUCTION
Two-photon ﬂuorescence ﬂuctuation experiments are very
attractive for in vivo applications. The small optical observa-
tion volume allows our probing any location within a cell
with submicron resolution (Denk et al., 1990). Fluorescently
labeled proteins diffusing through the observation volume
give rise to spontaneous signal ﬂuctuations that provide
dynamic and static information about the system without the
need for external perturbation. The cellular environment is
much more complex than test-tube conditions. Autoﬂuores-
cence, spatial heterogeneity, and other factors complicate
ﬂuorescence ﬂuctuation experiments in living cells. Never-
theless, it has been shown that ﬂuctuation correlation spec-
troscopy measurements in living cells are quite feasible
(Berland, 1995; Brock et al., 1998; Politz et al., 1998). We
successfully demonstrated molecular brightness measure-
ments of EGFP in cells using photon counting histogram
(PCH) analysis (Chen et al., 2002). Molecular brightness
characterizes the average detected photon count rate of
a ﬂuorophore. Its value depends on instrumental parameters,
such as the excitation wavelength and the quantum yield of
the detector. If instrumental parameters are kept constant,
molecular brightness characterizes a photophysical property
of the ﬂuorescent molecule.
Molecular brightness is a useful marker for monitoring
protein association. If a ﬂuorescently labeled protein diffuses
through the observation volume, it will produce a burst of
detected photons. The average photon count rate of these
bursts determines the molecular brightness of the labeled
protein. If such a protein associates to form a homodimer, the
new complex will carry two ﬂuorescent labels. Diffusion of
the complex through the observation volume will produce,
on average, twice as many photons than is the case for the
monomeric protein, because two independently ﬂuorescing
molecules are participating. Consequently, the molecular
brightness of the dimer is twice that of the monomer (Mu¨ller
et al., 2000). To measure over wide concentration ranges as
frequently encountered in cells, a new PCH model was
developed that takes nonideal detector effects into account
(Hillesheim and Muller, 2003). Using this new theory, we
recently demonstrated that brightness analysis provides a
quantitative approach to study homodimer formation in cells
(Chen et al., 2003).
Here, we expand brightness analysis to the case of binary
protein mixtures to quantify hetero- and homointeractions
between them. The relative ratio of expressed proteins varies
from cell to cell, and a method that determines the co-
expression ratio is needed. Each protein species is marked
with its own ﬂuorescent marker. We use the ﬂuorescent
proteins CFP and YFP in this study. The spectral difference
in their ﬂuorescence emission is used to determine the
coexpression ratio of both proteins from a dual-color inten-
sity ratio measurement and the independently determined
brightness of the ﬂuorescent markers. In addition, we have to
account for energy transfer between CFP and YFP. We use
ﬂuorescence lifetime measurements of the donor to charac-
terize an apparent ﬂuorescence resonance energy transfer
(FRET) efﬁciency, which is used to connect the experimen-
tally measured intensity ratio with the coexpression ratio.
Once the coexpression ratio of a cell is established, we
switch from the dual-channel setup to a single-channel
brightness experiment and perform PCH analysis to
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determine the molecular brightness of protein complexes.
We developed a theory to describe the inﬂuence of FRET on
brightness analysis. By choosing the right excitation con-
ditions we are able to eliminate the inﬂuence of FRET on the
brightness of a heterodimer that contains a donor-acceptor
pair. We choose excitation conditions where the brightness
of CFP and YFP are virtually the same. Thus, a heterodimer
will appear twice as bright as the corresponding monomers.
This allows us to take advantage of our existing single-
channel PCH theory to probe the interactions between the
proteins. In other words, we do not separate species by color,
but solely by their brightness difference. To distinguish
homo- from heterodimers, the excitation wavelength is
changed to make CFP ‘‘dark,’’ so that we monitor the molec-
ular brightness of YFP fusion proteins only.
We choose the ligand-binding domain of the two nuclear
receptors, retinoid X receptor (RXR) and retinoic acid
receptor (RAR), as our model system. We previously exam-
ined the behavior of each of these proteins in cells with
brightness analysis (Chen et al., 2003). Because RXRLBD
is able to form a heterodimer with RARLBD and also a
homodimer with itself, it is a suitable system to test our
technique. Homodimer formation depends on the presence of
ligand and offers an additional mechanism to control the
composition of the mixture. We present two-photon ﬂuo-
rescence ﬂuctuation experiments of cells expressing both
proteins and demonstrate that RXRLBD forms a very tight
heterodimer with RARLBD. Homodimer formation of
RXRLBD requires the presence of ligand and is less tight
than the heterodimer. Consequently, we only observed
homodimers when the concentration of RXRLBD exceeds
the concentration of RARLBD. Our results demonstrate the
potential of brightness analysis for quantitative character-
ization of complex protein interactions in cells.
THEORY
The average ﬂuorescence intensity ÆFæ is given by
ÆFæ ¼ hsðlexÞfInex
 
N ¼ lN; (1)
with the absorption cross-section s(lex) at the excitation
wavelength lex, the ﬂuorescence quantum yield f, the
excitation intensity Iex at the sample, and the number of
molecules N in the observation volume. The factor h takes
the detection efﬁciency of the optics and the detector into
account. The factor n equals 1 for one-photon excitation and
is 2 for two-photon excitation. The product of the factors
within the bracket describes the photon count rate of a single
molecule (Mu¨ller, 2004). The molecular brightness e is given
by the product of the photon count rate and the sampling time
at the detector,
e ¼ lT: (2)
Equation 2 is valid if the diffusion time is much shorter than
the sampling time T.
Our dual-channel detection path contains a dichroic that
splits the ﬂuorescence into two detection channels according
to color. We label the detection channel as red and green.
The subscripts (r) and (g) are used to denote properties of the
red and green channel, respectively. If no photons are
absorbed by the dichroic mirror the single-channel photon
count rate is simply the sum of the photon count rates in each
detection channel,
l ¼ lðrÞ1 lðgÞ: (3)
Measuring the intensity ratio of a ﬂuorescent dye deter-
mines its brightness and photon count ratio,
r ¼ ÆFæ
ðrÞ
ÆFæðgÞ
¼ Nl
ðrÞ
Nl
ðgÞ ¼
l
ðrÞ
l
ðgÞ ¼
eðrÞ
eðgÞ
: (4)
This allows us to determine the brightness ratio rCFP of CFP
and the brightness ratio rYFP of YFP, which characterizes the
relative brightness of the proteins with the two-channels
setup.
Now, let us consider a mixture of two proteins, A and B,
which are noninteracting. Protein A and B are labeled with
CFP and YFP, respectively. If the two proteins do not in-
teract, then the intensity ratio of the two detection channels
rF ¼ ÆFæ(r)/ÆFæ(g) is given by
rF ¼
rNrl
rYFP
ð11 rYFPÞ1
rCFP
ð11 rCFPÞ
rNrl
1
ð11 rYFPÞ1
1
ð11 rCFPÞ
; (5)
where the parameter rl ¼ lYFP/lCFP is the brightness ratio
between YFP and CFP, and rN ¼ NA,total/NB,total is the total
number of protein A over protein B, which is also the ratio of
the total number of YFP over CFP molecules. Experimen-
tally, rl, rF, rYFP, and rCFP can be determined independently,
and rN is calculated from Eq. 5.
For interacting proteins one has to take ﬂuorescence
resonance energy transfer (FRET) into account. If FRET is
present, the donor ﬂuorescence will quench, and the acceptor
ﬂuorescence will enhance. Consequently, the intensity ratio,
rF, will be inﬂuenced by the presence of energy transfer. Let
ÆFDæ be the ﬂuorescence intensity of a donor in the absence
of FRET. Energy transfer to an acceptor molecule leads to
a reduction of the ﬂuorescence ÆFDæ of the donor,
ÆFDæ ¼ ð1 EÞÆFDæ; (6)
where E is the efﬁciency of the energy transfer. Conse-
quently, the photon count rate of a single donor molecule lD
in the presence of FRET is related to the photon count rate of
the donor molecule lD in the absence of FRET by
ÆlDæ ¼ ð1 EÞÆlDæ: (7)
The ﬂuorescence of the acceptor molecule ÆFAæ without
FRET is given by
ÆFAæ ¼ hsAfAInex
 
NA ¼ lANA; (8)
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with lA as the photon count rate of the acceptor.
The presence of FRET in an acceptor-donor complex
leads to an enhancement of the ﬂuorescence ÆFAæ of the ac-
ceptor molecule,
ÆFAæ ¼ hsAfAInex
 
NAD1 hsDEfAI
n
ex
 
NAD
¼ 11sD
sA
E
 
ÆFAæ; (9)
where NAD equals the number of acceptor-donor complexes.
Because the ﬂuorescence intensity is related to the photon
count rate of a single molecule by ÆFAæ ¼ lANAD; the photon
count rate of the acceptor molecule in the presence of FRET
is given by
l

A ¼ 11
sD
sA
E
 
lA: (10)
In addition to the efﬁciency E of energy transfer one needs to
consider the ratio of the excitation cross sections of the donor
and acceptor molecule at the excitation wavelength. Equa-
tions 7 and 10 describe the inﬂuence of FRET on the photon
count rate of acceptor and donor molecules. Multiplying
both equations with the sampling time T describes, according
to Eq. 2, the inﬂuence of FRET on the brightness of the
donor and acceptor. Usually we will detect ﬂuorescence from
both the acceptor and the donor in the detection channel, and
we have to determine the brightness of the protein complex.
The photon count rate of a heterodimer containing an
acceptor-donor pair is thus given by
l

Dimer ¼ lA1 lD ¼ ðlA1 lDÞ1E
sD
sA
lA  lD
 
: (11)
For example, if the donor and acceptor molecule are
identical, such as is the case for a homodimer, the brightness
of the dimer is twice the brightness of the monomer,
lhomo ¼ 2l; independently of homo-energy transfer occur-
ring between the identical ﬂuorophores.
We now speciﬁcally consider the CFP-YFP ﬂuorescence
pair. CFP serves as the donor and YFP is the acceptor. The
two-photon cross sections of both ﬂuorescent proteins are at
an excitation wavelength of 905 nm identical (Zipfel et al.,
2003), sD(905 nm)/sA(905 nm)  1. In addition, the photon
count rate of CFP and YFP measured at this excitation
wavelength in our single-channel setup is identical within
10%, lA lD. For this special case FRET is not affecting the
brightness of protein complexes containing both CFP
and YFP. For example, a heterodimer that carries a CFP
and YFP label leads to a photon count rate of lDimer 
ðlCFP1lYFPÞ ¼ 2l;which is independent of FRET.We usel
to indicate the photon count rate of a single ﬂuorescent
protein.
Let us consider a mixture of two monomers (A and B) and
their dimer AB. Each monomer of A carries a CFP molecule
and each monomer B carries a YFP label. The FRET efﬁci-
ency between the donor and acceptor of the heterodimer is E.
The ﬂuorescence intensity in detection channel (i) of such
a mixture is given by
ÆFæðiÞ ¼ ÆFAæðiÞ1 ÆFBæðiÞ1 ÆFABæðiÞ: (12)
Using photon count rates, Eq. 12 becomes
ÆFæðiÞ ¼ lðiÞCFPNA1lðiÞYFPNB1 lðiÞCFPð1EÞ1lðiÞYFPð11EÞ
h i
NAB;
(13)
where we used the fact that sCFP/sYFP  1 for excitation at
905 nm. The total number of proteins A is NA,total ¼ NA 1
NAB, and the total number of proteins B is similarly given by
NB,total ¼ NB 1 NAB. We deﬁne the degree of dimerization
by
fD ¼ NAB
NA; total
: (14)
We now rewrite the intensity ratio rF¼ ÆFæ(r)/ÆFæ(g), which
was introduced in Eq. 5 for noninteracting proteins, for the
case of interacting proteins,
rF ¼
rl
rYFP
ð11 rYFPÞðrN1 E˜Þ1
rCFP
ð11 rCFPÞð1 E˜Þ
rl
1
ð11 rYFPÞðrN1 E˜Þ1
1
ð11 rCFPÞð1 E˜Þ
: (15)
We introduced the apparent FRET efﬁciency E˜; which is
related to the FRET efﬁciency E of the dimer by E˜ ¼ EfD:
Solving Eq. 15 for rN yields
rN ¼ ðrF  rCFPÞðrYFP  rFÞ
ð11 rYFPÞ
ð11 rCFPÞrlð1 E˜Þ  E˜: (16)
The only parameter unknown in the above equation is the
apparent FRET efﬁciency, which will be determined from
ﬂuorescence lifetime measurements.
The ﬂuorescence decay of the donor in the absence of
FRET, FD(t) ¼ aD exp(t/tD), changes to FD*(t) ¼ aD
exp(t/tD*) in the presence of FRET. For a multi-
exponential decay process, F(t) ¼ +ai exp(t/ti), we use
the average lifetime Ætæ deﬁned by
Ætæ ¼ +
i
aiti=+
i
ai: (17)
This deﬁnition of the average lifetime is proportional to the
average ﬂuorescence intensity ÆFæ. The FRET efﬁciency is
usually determined from measurements of the donor ﬂuo-
rescence or from its lifetime in the presence and absence of
FRET (Lakowicz, 1999),
E ¼ 1 ÆF

Dæ
ÆFDæ
¼ 1 Æt

Dæ
ÆtDæ
; (18)
where ÆtDæ is the ﬂuorescence lifetime in the presence of
FRET and ÆtDæ is the lifetime in the absence of FRET. We
observe ﬂuorescence from a mixture of monomers A without
FRET and dimers AB that undergo FRET. The ﬂuorescence
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intensity is given by Æ~FDæ ¼ ð1 fDÞÆFAæ1 fDÆFABæ; which
leads to an apparent FRET efﬁciency of
E˜ ¼ 1 Æ~t

Dæ
ÆtDæ
; (19)
where Æ~tDæ is the average lifetime of the mixture,
Æ~tDæ ¼ ð1 EfDÞÆtDæ: (20)
We previously developed an improved PCH theory to
examine protein interactions in living cells over a wide
concentration range (Chen et al., 2003). The low laser power
used in cellular applications and the high concentration of
proteins typically encountered leads to a signal/noise ratio
that does not allow the direct resolution of a monomer/dimer
equilibrium. Instead, we measure an apparent brightness that
contains contributions of the brightnesses of the monomer
and the dimer. The apparent molecular brightness was deter-
mined by analyzing data using PCH and moment analysis
(Chen et al., 1999; Qian and Elson, 1990). For a mixture of
species the apparent brightness is given by a nonlinear
combination of the brightness ei and the occupation number
Ni of each species (Chen et al., 2003),
eapp ¼
+
i
e2iNi
+
i
eiNi
: (21)
The apparent brightness of a monomer/dimer mixture will
lie between the brightness values of the monomer and dimer,
eapp ¼ e
2
MNM1 e
2
DND
eMNM1 eDND
; (22)
where eM and eD are the brightness values, and NM and ND
are the occupation numbers of the monomer and dimer,
respectively. Because both CFP and YFP have virtually
identical brightness values at an excitation wavelength of
905 nm in our single-channel setup, all monomeric proteins
carry the brightness eM and all dimers have a brightness of eD
¼ 2eM. This means that we cannot distinguish between
proteins labeled with CFP and YFP by brightness analysis,
nor can we distinguish between a homodimer and a hetero-
dimer. We perform an additional measurement at a different
excitation wavelength where only the acceptor YFP is
excited in order to distinguish homo- from heterodimers.
METHODS
Experimental setup
A mode-locked Ti:Sapphire laser (Tsunami, Spectra Physics, Mountain
View, CA) pumped by an intracavity doubled Nd:YVO4 laser (Spectra
Physics) serves as source for two-photon excitation. The laser produces 100-
fs pulses with a repetition frequency of 80 MHz (tunable between 700 and
1000 nm). The experiments were carried out using a Zeiss Axiovert 200
microscope (Carl Zeiss, Thornwood, NY) with a 633 Plan Apochromat oil
immersion objective (NA¼ 1.4). The power at the sample was determined by
measuring the laser power directly after the objective.We used a power of 0.5
mW at the sample for the cell measurements at all wavelengths. A modiﬁed
microscope’s turret was used for all cellular measurements. In addition to the
ﬁlter cubeused for theﬂuorescent light path, another ﬁlter cubewith a dichroic
(ChromaTechnology, Brattleboro, VT) for two-photon excitationwas added,
rotated by 90 with respect to the original cube. This arrangement allows the
laser beam to enter the microscope turret from the side, while at the same time
preserving the ﬂuorescence microscope capabilities of the instrument. We
used the ﬂuorescence path of the microscope to locate and position cells and
subsequently switched to two-photon microscopy for ﬂuctuation experi-
ments. Cells are mounted on an electronic stage (MS-2000 XYZ, ASI,
Eugene, OR). The location of eachmeasurement within cells is recorded from
the electronic readout of the x,y position of the stage.
The ﬂuorescence is sent to the bottom port for intensity ratiometric
measurements. A dichroic mirror with a center wavelength of 525 nm
(525DCXRU, Chroma Technology) splits the ﬂuorescence into two detec-
tion channels and the intensities of the dual-color experiment are recorded by
two avalanche photo diodes (APD) (Model SPCM-AQR-14, Perkin-Elmer,
Vaudreuil, Canada). Single-color brightness measurements are performed
by sending the ﬂuorescence to the side port. The ﬂuorescence is recorded by
another APD (Model SPCM-AQR-14). The data acquisition time for
measurements of the intensity ratio is on the order of 5 s, whereas brightness
measurements require on the order of 50 s. The TTL-output of each APD
unit is connected to a PCI data acquisition card (ISS, Champaign, IL), which
stores the complete sequence of photon counts using a sampling frequency
of 20 kHz. The recorded photon counts were stored and analyzed with pro-
grams written for IDL 5.4 (Research Systems, Boulder, CO).
A time-correlated single photon counting module was used to measure
ﬂuorescence lifetimes (TimeHarp 200, Picoquant, Germany). Monitoring the
laser pulses with a photodiode (DET210, Thorlabs, Newton, NJ) provides the
synchronization signal. The ﬂuorescence signal was monitored with a PMT
(H7421-40, Hamamatsu, Japan) under magic-angle conditions. A bandpass
ﬁlter (FF495-EX01-25, Semrock, Rochester, NY) was placed in front of the
PMT to block the light emitted from YFP. The ﬂuorescence ﬂuctuation
lifetime data are analyzed with GLOBALS Unlimited (Urbana, IL).
Expression vectors and cell measurements
RXRLBD-YFP, RARLBD-CFP, and RARLBD-YFP plasmids are sub-
cloned from existing RXRLBD-EGFP and RARLBD-EGFP plasmids (Chen
et al., 2003) using pECFP-C1 and pEYFP-C1 (Clontech, Palo Alto, CA).
CFP-RARLBD-YFP was constructed by inserting a PCR-ampliﬁed
YFP fragment into RARLBD YFP SacII and BamHI sites. All sequences
were veriﬁed by automatic sequencing. CV-1 cells were obtained from
ATCC (Manassas, VA) and maintained in 10% fetal bovine serum (Hyclone
Laboratories, Logan, UT) and EMEMmedia. Transfections were carried out
by using transfectin (Bio-Rad, Hercules, CA) according to manufacturer’s
instructions. The RXR agonist used in this study is AGN 194209 (Farooqui
et al., 2003).
Cells were subcultured into eight-well coverglass chamber slides
(Naglenunc International, Rochester, NY). Before conducting measure-
ments, the growth media was exchanged to Dulbecco’s phosphate-buffered
saline with calcium and magnesium (Biowhittaker, Walkersville, MD). RXR
agonist was added to the media at 3-mM concentration. Fluorescence
ﬂuctuation spectroscopy measurements were performed 10 min after the
addition of ligand. To estimate the uncertainty in measuring the brightness in
cells, we divided the data set of a single measurement into shorter segments,
calculated the brightness of each segment, and determined the standard
deviation in brightness of one segment. We estimate the experimental error
in brightness for the complete data set by dividing the standard deviation by
the square-root of the number of segments. This approach assumes statistical
independence between individual segments. We checked many of our cell
measurements and consistently recovered errors between 4% and 8%.
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Control experiments
Photobleaching and saturation of the ﬂuorophores would complicate data
analysis of ﬂuorescence ﬂuctuation experiments. We conﬁrmed that, for the
power range used in this study, photobleaching and saturation are absent
by performing control experiments as previously described (Chen et al.,
2003). Before starting the actual experiments, we always perform a brightness
calibration by measuring cells that express RARLBD-YFP, RARLBD-
CFP, and CFP-RARLBD-YFP, because we previously showed that
RARLBD remains monomeric in cells. Measurements of RARLBD-YFP
and RARLBD-CFP serve to establish the brightness eMonomer of a monomer,
and measurements on CFP-RARLBD-YFP were performed to check that the
total brightness of the two ﬂuorophores is additive. For experiments with an
excitation wavelength of 965 nm, where CFP is dark, we used RARLBD-
YFPandCFP-RARLBD-YFP to calibrate the brightness of themonomer.The
total concentration of the expressed proteins in cells was determined using
the brightness of a monomer and the total measured intensity as previously
described (Chen et al., 2003). At 905 nm we determine the total protein
concentration of RXRLBD-YFP and RARLBD-CFP. At 965 nm we only
determine the protein concentration of RXRLBD-YFP, because CFP is dark.
RESULTS
Protein coexpression ratio from dual-color
intensity measurements
The absolute concentration of an expressed protein varies
widely from cell to cell after transient transfection. Since the
expression level of proteins is not directly under our exper-
imental control, it is necessary to determine the expressed
protein ratio in each cell from experiment. This is especially
important for single-channel brightness analysis, where
knowledge of the expressed protein ratio provides an impor-
tant constraint for the analysis and interpretation of data. In
this study CFP and YFP serve as ﬂuorescent tags to uniquely
mark each protein species. Dual-color detection is used to
determine the expression ratio of the two fusion proteins
from the intensity ratio of the two detection channels. For the
moment we restrict ourselves to the case of two non-
interacting protein species. In other words, there is no energy
transfer between the ﬂuorescent proteins. We excite CFP and
YFP at 905 nm and split the ﬂuorescence emission into two
channels with a dichroic ﬁlter. The emission spectra of CFP
and YFP strongly overlap, and each channel contains signal
contributions from both proteins. We therefore ﬁrst de-
termine the intensity ratio (see Eq. 4) for each protein by
measuring cells transfected with either CFP or YFP fusion
protein. We determined intensity ratios of rCFP ¼ 0.4 and
rYFP ¼ 2.3 for CFP and YFP, respectively. These intensity
ratios are not sufﬁcient to determine the coexpression ratio.
The intensity ratio of a mixture depends also on the bright-
ness of the individual proteins. A brighter protein will
contribute more to the intensity ratio of the mixture than a
dimmer protein. We measured the brightness of CFP and
YFP in 10 cells each using our single-color setup and cal-
culated an averaged brightness ratio of rl ¼ 1.1 between
YFP and CFP.
If protein A is labeled with CFP and protein B is labeled
with YFP, then the coexpression ratio rN ¼ NA,total/NB,total of
the two proteins equals the ratio rN ¼ NYFP,total/NCFP,total of
the total number of CFP and YFP proteins. The solid line in
Fig. 1 is a theoretical curve of the intensity ratio as a function
of protein coexpression ratio calculated from Eq. 5 based on
the experimental parameters determined for CFP and YFP.
Thus, an intensity ratio of rF ¼ 1.0 corresponds to a 1:1
coexpression of both proteins in the absence of FRET.
Protein coexpression ratio in the presence
of FRET
We now determine the coexpression ratio of the fusion
proteins RARLBD-CFP and RXRLBD-YFP. But ﬁrst we
perform control experiments on cells either expressing
RARLBD-CFP or RXRLBD-YFP. The measured intensity
ratios of the two proteins are identical to the ratios obtained
earlier for CFP and YFP. Their molecular brightness values
are also within experimental error identical to the brightness
values of CFP and YFP (data not shown).
It is known that RARLBD and RXRLBD form a tight
heterodimer in vitro. Because CFP and YFP are a good FRET
pair, we suspect that dimer formation of RARLBD-CFP and
RXRLBD-YFP in vivo leads to energy transfer between the
ﬂuorescent proteins. The presence of FRET quenches the
intensity of CFP and raises the intensity of YFP, which affects
the value of the intensity ratio measurements. Because the
intensity ratio is needed to determine the coexpression ratio,
we developed an expression (Eq. 15) that takes the inﬂuence
FIGURE 1 Intensity ratio rF as a function of the coexpression ratio rN ¼
NYFP/NCFP. The solid line represents the relationship between the intensity
ratio and the coexpression ratio in the absence of FRET. The dashed line was
calculated assuming a stoichiometric binding model and a FRET efﬁciency
of 27%. An intensity ratio of 1.25 (dotted arrow) leads to a coexpression
ratio of ;2 (solid arrow) in the absence of FRET, while representing
equimolar expression in the presence of FRET (dashed arrow). Each shaded
bar indicates the range of intensity ratios selected for further brightness
analysis in our experiments.
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of FRET quantitatively into account. Independent measure-
ments are needed to determine the exact amount of the
apparent FRET efﬁciency between RARLBD-CFP and
RXRLBD-YFP. We measure the ﬂuorescence lifetime of
the donor CFP with a narrow bandpass ﬁlter that completely
cuts off the YFP emission. The apparent FRET efﬁciency is
determined form Eq. 19 by comparing the ﬂuorescence
lifetime of the protein mixture Æ~tDæ with the ﬂuorescence
lifetime of RARLBD-CFP alone ÆtDæ. We performed a series
of measurements on cells that coexpress RARLBD-CFP and
RXRLBD-YFP. For each cell, we ﬁrst measure the dual-color
intensity ratio by directing the ﬂuorescence emission to the
emission port with the dual-channel setup. Then we redirect
the ﬂuorescence emission to another microscope port to
perform ﬂuorescence lifetime measurements. Fig. 2 graphs
the ﬂuorescence intensity ratio of RARLBD-CFP and
RXRLBD-YFP against the average ﬂuorescence lifetime
Æ~tDæ of the donor CFP. There are two striking features to be
noted. First, the average ﬂuorescence lifetime of the donor
changes as a function of intensity ratio, indicating the
presence of FRET. Second, there is a unique lifetime for
each intensity ratio. Because each intensity ratio encodes a
particular coexpression ratio, the lifetime depends only on the
coexpression ratio.
The degree of dimerization of a reaction depends on the
absolute concentration of both proteins and their dissociation
coefﬁcient KD. Concentrations below the value of the KD
lead to a dimer fraction that is lower than the maximum
possible. Concentrations much larger than the KD value lead
to complete dimerization of every available protein pair. This
limiting case is also called the stoichiometric binding regime,
because the effect of entropy is negligible. We expect to see,
for a 1:1 coexpression ratio with increasing absolute protein
concentration, a steady increase in the dimer fraction until it
reaches a limiting value of 1. Because the average lifetime of
the donor depends on the dimer fraction according to Eq. 20,
we also expect to see, for a 1:1 coexpression ratio, that the
lifetime changes as a function of protein concentration. How-
ever, no changes in lifetime are observed, although the protein
concentrations measured span more than one order-of-
magnitude for a given intensity ratio. The only explanation
consistent with the experimental observation is that all our
measurements are taking place under conditions of stoichio-
metric binding. Thus, theKD of the heterodimermust bemuch
lower than 500 nM, which corresponds to the lowest protein
concentration shown in Fig. 3. An in vitro study determined
a KD of ;400 pM for the heterodimer of RXRLBD and
RARLBD (Dong and Noy, 1998). Thus our result is con-
sistent with the in vitro study, since we expect similar binding
properties in vivo and in vitro. Stoichiometric binding leads to
a simple relationship between the dimer fraction fD and the
coexpression ratio rN ¼ NRXRLBD-YFP/NRARLBD-CFP,
fD ¼ rN for rN# 1
fD ¼ 1 for rN. 1: (23)
In other words, the dimer fraction depends only on the co-
expression ratio and is independent of the absolute value of
the protein concentrations.
Because of energy transfer between RARLBD-CFP and
RXRLBD-YFP, the lifetime of the donor RARLBD-CFP
varies as a function of the intensity ratio. When RARLBD-
CFP is in great excess, we expect that the average ﬂuo-
rescence lifetime is similar to that of RARLBD-CFP alone.
As the RXRLBD-YFP concentration increases, the ﬂuores-
cence lifetime of RARLBD-CFP decreases, because of the
presence of FRET in the heterodimers, and will level off
once all RARLBD-CFP form heterodimers. We indeed
observe, in Fig. 2, a decrease in ﬂuorescence lifetime as
a function of intensity ratio. At an intensity ratio of 0.4, only
RARLBD-CFP is present, and the ﬂuorescence lifetime ÆtDæ
of the donor is 2.38 ns. This lifetime decreases with in-
creasing intensity ratio until the dimer fraction fD equals 1.
The limiting lifetime value of 1.75 ns corresponds to a FRET
efﬁciency of E ¼ 0.27. The effective FRET efﬁciency is
given by E˜ ¼ EfD; which allows us to calculate the intensity
ratio and the ﬂuorescence lifetime for stoichiometric binding
using Eqs. 15 and 20. The solid line in Fig. 2 was calculated
using the measured intensity ratios of the ﬂuorescent pro-
teins, rCFP and rYFP, their brightness ratio rl, and a FRET
efﬁciency of E ¼ 0.27. We used the same parameters to
calculate the relationship between the coexpression ratio rN
and the intensity ratio rF for stoichiometric binding from Eq.
15, which is shown in Fig. 1 as a dashed line. The solid line
FIGURE 2 Fluorescence lifetime of the donor RAR-CFP as a function of
the intensity ratio of RXR-YFP and RAR-CFP coexpressed in CV-1 cells.
The symbols are the experimentally determined ﬂuorescence lifetime values
of RAR-CFP, and the solid line is the theoretical predication assuming
stoichiometric binding with an apparent FRET efﬁciency of 27%. The
ﬂuorescence lifetime ofRAR-CFP is 2.38 ns in the absence of RXR-YFP. The
lifetime of RAR-CFP decreases as the concentration of RXR-YFP is raised
and reaches a limiting value once all RAR-CFP are bound to RXR-YFP.
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represents the case without FRET. The differences between
the two curves clearly highlight the importance of including
FRET into the model. For example, a 1:1 coexpression is
characterized by an intensity ratio of 1.0 in the absence of
FRET, but increases to a value of 1.25 in the presence of
27% FRET. Note that the intensity ratio of 1.25 corresponds
to a 1:2 CFP/YFP coexpression ratio in the absence of FRET.
In summary, we established a relationship between the in-
tensity ratio and the coexpression ratio for the brightness ex-
periments that follow.
Single channel molecular brightness
measurements on heterocomplexes
Moment or PCH analysis of ﬂuorescence ﬂuctuation ex-
periments provides information about the brightness of
proteins. We have used brightness analysis to detect
homointeractions between proteins in cells (Chen et al.,
2003). This type of analysis can also be applied to detect
heteroprotein interactions using single-color ﬂuorescence
ﬂuctuation spectroscopy. Let us illustrate the concept using
a special case. Two proteins A and B are coexpressed with
a 1:1 concentration ratio. Protein A is labeled with YFP and
protein B is labeled with CFP. At an excitation wavelength
of 905 nm, CFP fusion protein has almost the same
brightness as YFP fusion protein. Thus, from a molecular
brightness point of view, these two species are indistinguish-
able. Let us further assume that protein A exists in three
different states, as monomer A, as homodimer A2, and as
heterodimer AB. Protein B only exists in two states, as
monomer B and as heterodimer AB. Table 1 summarizes the
apparent brightness values that result from a number of
different combinations of these protein states. If the
brightness eM of the monomers of A and B is e, then the
brightness eD of the heterodimer AB and the homodimer A2
is 2e.
TABLE 1 Apparent brightness of binary protein mixtures
Apparent brightness
e e 2e e 1e4 2e 1e4 2e
e 0 e e e 2e
Each protein, A and B, carries a ﬂuorophore with a brightness of e. The apparent brightness of the monomeric proteins is e. The other panels show the
apparent brightness for different protein mixtures. To facilitate experimental distinction between these different mixtures, we also consider the case where
only A carries a ﬂuorescent label and B is nonﬂuorescent.
FIGURE 3 Relative brightness of RARLBD-CFP and RXRLBD-YFP in CV-1 cells with intensity ratios between 1.15 and 1.35. This range of intensity
ratios corresponds to coexpression ratios NRXRLBD-YFP/NRARLBD-CFP from 0.9 to 1.2. (A) At an excitation wavelength of 905 nm CFP and YFP are equally
bright, and the relative brightness of the heterodimer is;2. (B) At 965 nm, only YFP is excited, and the apparent brightness of the heterodimer is reduced to the
YFP brightness. The relative brightness of the heterodimer is virtually identical in the absence (n) and in the presence (n) of RXR agonist, which indicates that
RXRLBD is unable to form homodimers in the presence of equal concentrations of RARLBD. The experimental error in brightness is shown for selected cells.
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For convenience, we introduce the relative brightness re,
which is the ratio of the apparent brightness to the brightness
of a monomer, re ¼ eapp/eM. A mixture of noninteracting
monomers (A1B) results in a brightness of e, which is
equivalent to a relative brightness of 1. For a mixture of
monomers in equilibrium with the heterodimer (A1B1AB)
the relative brightness will lie between 1 and 2. The same
situation applies for a mixture of homodimers A2 and
monomeric B (A21B). The relative brightness of this mixture
has a value between 1 and 2. The exact value depends on the
composition of the mixture and is determined by
re ¼
eapp
eM
¼ 11 rN1 2fD
11 rN
; (24)
which we derived from Eq. 22 for the special case of a dimer
brightness eD ¼ 2e. As is apparent from Table 1, although it
is very easy to distinguish a pure heterodimer from a
monomer, it is much more tricky to differentiate a hetero-
dimer-monomer mixture (AB1A1B) from a homodimer-
monomer mixture (A21B), because of the overlapping
apparent brightness values in both cases. Thus, in general it
will not be possible to identify the sample composition by
measurement of the apparent brightness alone. To address
this problem, we render CFP nonﬂuorescent by moving the
two-photon excitation wavelength to 965 nm. Consequently,
the brightness of protein B drops to 0 and the brightness
of the heterodimer AB reduces from 2e to the brightness
e of protein A (Table 1). The apparent brightness of the
heterodimer-monomer mixture (AB1A1B) reduces to e,
whereas the brightness of the homodimer-monomer mixture
(A21B) increases to 2e. In other words, the composition of
protein mixtures can be identiﬁed by selectively turning on
and off the brightness of ﬂuorescent proteins by changing the
excitation wavelength.
The molecular brightness of RARLBD-CFP and
RXRLBD-YFP in cells
We previously demonstrated that the brightness of RARLBD
in cells is equal to that of a monomer in the presence and
absence of its agonist, all-trans-retinoic acid. In other words,
RARLBD does not form homocomplexes. RXRLBD is
mostly monomeric based on brightness in the absence of
9-cis-retinoic acid, but exhibits an increase in brightness at
high protein concentrations, which indicates the presence of
homocomplexes. Upon ligand addition, the apparent bright-
ness of RXRLBD increases for all concentrations measured
and reaches the brightness of a dimer at high protein con-
centrations. This result is consistent with a shift of the
homodimer-monomer equilibrium to a higher binding afﬁnity.
In this study, we wish to distinguish homo- and hetero-
dimer formation of RXRLBD and RARLBD by applying
molecular brightness analysis to cells transfected with
RARLBD-CFP and RXRLBD-YFP. For each cell we per-
form a dual-channel intensity measurement to determine its
protein expression ratio, followed by a single-channel
brightness measurement at 905 nm to establish the brightness
of the average protein complex. We also record the position
of each cell using the electronic controlled stage of the mi-
croscope. This procedure allows us to revisit cells and mea-
sure brightness with an excitation wavelength of 965 nm
where only YFP is excited, which is essential for distinguish-
ing between heterodimers and homodimers of RXRLBD.
The same sequence of measurements is carried out after
addition of ligand. Fig. 3 shows the brightness ratio re of
cells with intensity ratios from 1.15 to 1.35, which cor-
responds to approximately equimolar expression of both
proteins. At an excitation of 905 nm, the relative brightness
values of the RARLBD-CFP/RXRLBD-YFP mixture is 2 at
all concentrations measured, thus indicating the presence of
a purely dimeric species (Fig. 3 A). The relative brightness
values are virtually unchanged upon adding RXR agonist.
Measuring the same cells at 965 nm reveals a relative
brightness of RXRLBD-YFP, which is 1 (Fig. 3 B). This
means that RXRLBD-YFP is not able to form homodimers
in the presence of equal amount of RARLBD, but must be
present as a heterodimer. In other words, our study conﬁrms
in vitro results that demonstrate that RARLBD forms a very
tight heterodimer with RXRLBD, and that RXRLBD cannot
form a homodimer in the presence of equimolar concen-
trations of RARLBD (Dong and Noy, 1998).
Next, we examine the power of brightness analysis by
studying situations where one of the protein components is in
excess. We ﬁrst choose cells that express more RARLBD-
CFP than RXRLBD-YFP. Speciﬁcally, we picked cells with
intensity ratios from 0.7 to 0.9, which corresponds to
concentration ratios NRXRLBD-YFP/NRARLBD-CFP ¼ 0.35–0.6.
The relative brightness measured at 905 nm as a function of
protein concentration is shown in Fig. 4 A. The relative
brightness is concentration-independent, and its value is
lower than that of a dimer. This reduced relative brightness
indicates the presence of a monomeric species. This is
expected, because the fraction of RARLBD-CFP, which is in
excess over the RXRLBD-YFP concentration, cannot ﬁnd
a heterobinding partner and has to be in monomeric form.
Upon adding RXR agonist, the relative brightness stays the
same, which indicates that the excess fraction of RARLBD-
YFP remains monomeric. Calculating the expected relative
brightness from Eq. 24 for concentration ratios of 0.35–0.6
predicts values between 1.5 and 1.75. This range is marked
as dotted lines in Fig. 4 A, and our data fall well between
these limits. To check our model we also measured the
brightness at 965 nm, where only YFP is excited (Fig. 5,
solid squares). The relative brightness of RXRLBD-YFP is
equivalent to that of a monomer. Thus, no homocomplexes
of RXRLBD-YFP are found. RXRLBD-YFP forms a tight
heterodimer with its partner RARLBD-CFP.
We also measured cells that express more RXRLBD-YFP
than RARLBD-CFP. Cells with intensity ratios of 1.5–1.7
were selected, which corresponds to concentration ratios
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NRXRLBD-YFP/NRARLBD-CFP ¼ 1.8–2.8. The relative bright-
ness values measured at 905 nm as a function of concen-
tration are shown in Fig. 4 B. Again, the relative brightness
of these cells is lower than the value required for a pure
dimer. We expect that both proteins form a tight heterodimer.
In addition, based on our previous study we anticipate that
RXRLBD-YFP remains essentially monomeric in the ab-
sence of ligand. This model allows us to calculate the ex-
pected relative brightness from Eq. 24, which gives values
from 1.5 to 1.75 (shown as dashed lines in Fig. 4 B). These
brightness predictions are in good agreement with our ex-
perimental data.
Adding RXR agonist increases the relative brightness
(open triangles in Fig. 4 B) to that expected for a purely
dimeric species. To better understand this behavior, we also
measured the brightness at 965 nm,where onlyYFP is excited
(open triangles in Fig. 5). The relative brightness in the
presence of RXR agonist is concentration-independent and
larger than that of YFP alone, but less than that of dimeric
YFP. This clearly demonstrates the presence of homocom-
plexes of RXRLBD-YFP. We introduce a simple model
where RXRLBD-YFP forms a tight heterodimer with
RARLBD-CFP, and any excess concentration of RXRLBD-
YFP forms a homodimer in the presence of RXR agonist. This
simple model ﬁts our data very well. Both the homodimer and
the heterodimer have a brightness of 2e at an excitation
wavelength of 905 nm. Thuswe expect a relative brightness of
2 in the presence of agonist as experimentally observed (see
triangles in Fig. 4 B). At an excitation wavelength of 965 nm
the relative brightness of the heterodimer is reduced to 1,
whereas the relative brightness of the homodimer remains 2.
Calculating the relative brightness for this model gives values
between 1.4 and 1.6, which are in good agreement with the
experimental data (see Fig. 5).
FIGURE 4 Relative brightness of RARLBD-CFP and RXRLBD-YFP in CV-1 cells at an excitation wavelength of 905 nm. (A) Cells with intensity ratios
from 0.7 to 0.9 (NRXRLBD-YFP/NRARLBD-CFP from 0.36 to 0.6). Excess of RARLBD leads to an apparent brightness (n), which is less than that expected for a full
dimer. Adding ligand leaves the apparent brightness (n) unchanged. (B) Cells with intensity ratios from 1.5 to 1.7 (NRXRLBD-YFP/NRARLBD-CFP from 1.8 to 2.8).
Excess of RXRLBD leads to an apparent brightness (n), which is less than that expected for a full dimer. Adding ligand restores the apparent molecular
brightness (n) of the mixture to that of a pure dimer population. The dashed lines correspond to the range of relative brightness values in the absence of ligand
and are calculated from the simple binding model discussed in the text.
FIGURE 5 Relative brightness of RARLBD-CFP and RXRLBD-YFP in
CV-1 cells in the presence of RXR agonist at an excitation wavelength of
965 nm. Cells with an excess of RARLBD (NRXRLBD-YFP/NRARLBD-CFP from
0.36 to 0.6) have an apparent brightness equal to monomeric RXRLBD-
YFP. Cells with an excess of RXRLBD (NRXRLBD-YFP/NRARLBD-CFP from
1.8 to 2.8) have an apparent brightness, which is larger than that of a
monomer, but less than that of a dimer. The dashed lines indicate the
relative brightness range expected from the binding model described in the
text.
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DISCUSSION
Determining the protein coexpression ratio is crucial for
a quantitative analysis of protein heterointeractions in cells.
We use a dual-color ﬂuorescence setup to determine the
coexpression ratio. Both CFP and YFP are conveniently
coexcited at 905 nm and have virtually the same molecular
brightness. Knowledge of this brightness and the measured
dual-color intensity ratio determine the coexpression ratio in
the absence of FRET. Calculating the coexpression ratio in
the presence of FRET requires an additional parameter, the
apparent FRET efﬁciency E˜; which is experimentally deter-
mined from Eq. 19 by lifetime measurements of the donor.
Ignoring FRET leads to a systematic bias when selecting
cells on the basis of dual-color intensity ratio measurements
as illustrated in Fig. 1. For example, an intensity ratio of 1.25
would be interpreted as a 1:2 coexpression ratio, although
actually reﬂecting a 1:1 expression ratio.
The term ‘‘apparent FRET’’ is used to indicate that not all
donor molecules are experiencing energy transfer. For
example, CFP in monomeric form will not contribute to the
FRET signal. The average lifetime of the donor Æ~tDæ is given
by a superposition of the lifetimes in the presence and absence
of FRET, Æ~tDæ ¼ fÆtDæ1f1ÆtDæ; where f and f1 represent
the normalized fraction of donor molecules, with and without
energy transfer, respectively. The apparent FRET efﬁciency is
deﬁned by E˜ ¼ 1 Æ~tDæ

ÆtDæ: As we have shown, our
model proteins RARLBD and RXRLBD form a very tight
heterodimer in vivo, and all our measurements are performed
at protein concentrations above the KD of the heterodimer. In
other words, we encounter stoichiometric binding, where the
degree of binding is solely determined by the ratio of the
protein concentrations. The simplicity of this binding model
allows us to perform an experimental test of our theory. The
average lifetime of the donor depends only on the intensity
ratio and is determined from Eqs. 23 and 16, as shown in Fig.
2. We observe a FRET efﬁciency of 27% for the heterodimer
of RARLBD-CFP and RXRLBD-YFP.
We would like to emphasize that measuring the average
donor lifetime, and thereby the apparent FRET efﬁciency, is
needed only for the accurate determination of the protein
coexpression ratio. The examination of protein-protein inter-
actions by brightness analysis does not rely on FRET. This
differs from traditional FRET spectroscopy, where a positive
FRET signal is needed to detect protein-protein interactions
(Day et al., 2001). The absence of a FRET signal, however,
cannot rule out protein association. Brightness analysis, on
the other hand, detects protein association by an increase of
the brightness, which occurs both in the presence and absence
of FRET. We choose experimental conditions where the
brightness increase is independent of FRET. This simpliﬁes
the interpretation of the experimentally measured brightness.
Brightness analysis also characterizes the formation of homo-
complexes, where FRET spectroscopy is unsuitable, and pro-
vides quantitative information about the degree of binding.
We introduced a theory that describes the inﬂuence of
energy transfer on the brightness of the donor and acceptor.
The brightness of the donor increases and the brightness
of the acceptor decreases as shown in Eqs. 7 and 10. The
brightness of a dimer that carries a donor-acceptor pair is
given by the sum of their brightnesses. It is important to note
that judicious selection of the excitation wavelength and
optical ﬁlters allows the brightness of the dimer to be inde-
pendent of energy transfer. For example, an excitation
wavelength where the two-photon cross-sections of the
donor and acceptor are identical, together with optical ﬁlters
that give identical brightness for donor and acceptor, are
ensuring a brightness of the dimer that is twice the brightness
of the monomer (see Eq. 11). These conditions are approx-
imately fulﬁlled for exciting the CFP/YFP pair at 905 nm.
The ratio of their two-photon cross sections is 1 (Zipfel et al.,
2003), and their brightnesses differ by only 10%. This dif-
ference in brightness is acceptable, given the experimental
uncertainties of cellular measurements.
Another condition required for a quantitative interpretation
of brightness is that the ﬂuorescence of the label is not
quenched by protein-protein interactions. We veriﬁed this
previously for the ﬂuorescent protein EGFP (Chen et al.,
2003). The same conclusion holds for the ﬂuorescent proteins
CFP and YFP (data not shown). We found that the molecular
brightness of RARLBD-CFP and RXRLBD-YFP is the same
as either CFP or YFP alone within the experimental un-
certainty of brightness experiments in cells.We also observed
doubling of the brightness when expressing both proteins in
a 1:1 ratio, as expected for a heterodimer in the absence of
quenching (shown in Fig. 3 A).
Endogenous RXR and RAR could interact with the
ﬂuorescently labeled RXRLBD and RARLBD, thereby in-
troducing a nonﬂuorescent background species. The conse-
quence of such a background species is the reduction of the
measured apparent brightness. We previously demonstrated
that endogenous RXR and RAR are undetectable in COS-1
cells (Chen et al., 2003). Here we use CV-1 cells, which are
closely related to COS-1. COS-1 is the SV40-transformed
CV-1 cell line. Thus, we expect that endogenous RXR and
RAR are absent in the CV-1 cell line. In addition, if endog-
enous protein were present, it would compete with labeled
protein in forming binding complexes. Complexes formed
between a labeled and an endogenous protein have a lower
brightness than complexes between labeled proteins, which
would result in a reduction of the apparent brightness to
values less than twice the monomer brightness. Our results in
Fig. 3 show that equimolar concentrations of RXRLBD and
RARLBD lead to a brightness of twice the monomer bright-
ness, indicating a pure species of labeled heterodimers. In
other words, the inﬂuence of endogenous protein is negligible
over the concentration range studied.
RXR is a unique nuclear receptor because it serves
as a heterodimer partner for many other nuclear receptors,
such as RAR, T3R, and VDR (Mangelsdorf et al., 1995).
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Previously, we have shown that RXRLBD is capable of
forming homodimers after ligand activation in cells. In this
study we examined RXRLBD in the presence of RARLBD.
We found that RXRLBD is not capable of forming homo-
dimers in the presence of an equal or higher concentration
of RARLBD. This demonstrates that the afﬁnity for the
heterodimer is much higher than the afﬁnity for the homo-
dimer. Our ﬁnding is in agreement with other studies using
puriﬁed proteins that conclude RAR and RXR form a very
tight heterodimer in vitro (Dong and Noy, 1998; Poujol et al.,
2003).
To clearly distinguish between hetero- and homodimers the
excitation wavelength was changed from 905 nm to 965 nm to
selectively excite the acceptor YFP. The two-photon cross-
section of YFP at this wavelength exceeds the cross-section of
CFP by ;20 times. In other words, the brightness of CFP is
approximately a factor-of-20 smaller than thebrightness ofYFP,
and can be safely ignored in most circumstances. Measuring
the brightness at both wavelengths provides a convenient
method to distinguish between homodimers and heterodimers
as illustrated in Table 1. Our experimental brightness values
are in good agreement with a simple binding model, where
RXRLBD and RARLBD form a tight heterodimer. Any
excess population of RXRLBD is a monomer in the absence
of ligand and forms homodimers in the presence of ligand.
Labeling of individual protein species with differently
colored dyes is an elegant approach for studying protein-
protein interactions. Analysis of such experiments with dual-
color ﬂuorescence ﬂuctuation spectroscopy is an obvious
choice, and has been primarily the focus of ﬂuorescence
cross-correlation analysis (Bacia et al., 2002). However, dual-
color cross-correlation analysis in living cells with ﬂuorescent
proteins is challenging. There are only a limited number of
ﬂuorescent proteins to choose from. For example, the CFP
andYFP pair, which is widely used for FRET studies, exhibits
strong spectral overlap. The spectral overlap leads to cross
talk between the detection channels and severely complicates
dual-channel cross-correlation analysis.
Dual-color PCH analysis offers another approach to
analyze ﬂuctuation experiments. We recently demonstrated
that it is possible to resolve a diluted CFP/YFP mixture in
vitro using dual-color PCH (Chen et al., 2004). However,
cellular experiments require measurements over a wide con-
centration range, and a dual-color PCH theory that takes
deadtime and afterpulsing of the photo detector into account
still needs to be developed. In addition, a quantitative treat-
ment of FRET in dual-color PCH is still missing. Thus, we
decided to focus on detecting homo- and heterointeractions,
not by differences in color, but solely based on brightness in
a single-channel setup. By exciting CFP and YFP at 905 nm
we eliminate brightness differences between the ﬂuoro-
phores and eliminate the inﬂuence of FRET on the brightness
of the heterodimer.
Our method of brightness analysis is applicable to other
protein systems as well. In our particular case, we take ad-
vantage of the tight binding between RXRLBD and
RARLBD. This results in a unique relationship between
the average ﬂuorescence lifetime of the donor and the
coexpression ratio as shown in Fig. 2. In general, the degree
of binding not only depends on the coexpression ratio but on
the absolute concentrations of the reactants as well. Mea-
suring the ﬂuorescence lifetime of the donor, the dual-color
intensity ratio, and the single-color brightness of each cell
determines the apparent FRET efﬁciency, the coexpression
ratio, and the brightness of the sample. The absolute protein
concentration is determined from the ﬂuorescence intensity.
Different excitation wavelengths are used to distinguish
between homo- and heterointeractions. Collecting brightness
data in this manner allows our distinguishing different bind-
ing models by comparing the experimental data with model-
dependent predictions.
CONCLUSIONS
Molecular brightness is inherently sensitive to the stoichi-
ometry of a protein complex. In the past, we demonstrated
that molecular brightness is a robust method for character-
izing the oligomerization of a homocomplex. Here, we show
that molecular brightness is capable to determine the com-
position of a heterocomplex as well. We demonstrate that
a lifetime and a dual-color intensity ratio measurement are
sufﬁcient to characterize the coexpression ratio. A theory
that describes the presence of energy transfer on brightness
was introduced and used to ﬁnd excitation conditions for
CFP and YFP that eliminate the inﬂuence of energy transfer
on the brightness of heterodimers. Brightness analysis was
applied to demonstrate heterodimer formation between
RXRLBD and RARLBD. In addition, by exciting at dif-
ferent wavelengths we were able to distinguish homodimer
and heterodimer complexes. Our theory allows a quantitative
interpretation of the brightness in terms of protein popula-
tions. We like to stress that this is the ﬁrst quantitative study
of both homo- and heterodimer formation in cells. In sum-
mary, brightness analysis is a promising tool for quantitative
analysis of protein-protein interactions in living cells.
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